Micropore HORIZON™ series

Micropore HORIZON™ systems bring Advanced Crossflow (AXF) technology into scalable, automated platforms designed to support particle engineering from development through to manufacturing.

Micropore HORIZON™ series

Micropore HORIZON™ systems bring Advanced Crossflow (AXF) technology into scalable, automated platforms designed to support particle engineering from development through to manufacturing.

Manufacturer Micropore Technologies
Product Series AXF series
Sample type Nanomedicines, Microspheres, Polymer nanoparticles, Crystals, Liposomes, Nucleic acid lipid nanoparticles (LNPs)
Application Emulsions, Liposome Processing & Mixing, Nanoparticle formulation
Formulation TechnologyAdvanced crossflow (AXF) mixing
Typical Total Flow Rate (L/Hr) 1-20 (HORIZON™ mini); 10-120 (HORIZON™ One); 10n-120n (HORIZON™ PRO)
Make product enquiry
Download product brochure

Product Overview

The Micropore HORIZON™ series enables precise, reproducible particle and emulsion formation, helping users simplify scale-up and improve process reliability

Built on proven Advanced Crossflow (AXF) technology, the HORIZON™ platform addresses one of the industry’s most persistent challenges—quickly and easily translating formulations from R&D to full-scale production.

Enabling low-shear emulsification and precise, controlled particle formation, the system delivers highly reproducible and reliable results across a wide range of applications, including pharmaceuticals, CDMOs, and encapsulation processes.

The HORIZON™ range has been thoughtfully designed with scalability and efficiency in mind. From the compact HORIZON™ mini for development and pilot-scale work, to the industrial-scale HORIZON™ one, and the fully customisable HORIZON™ PRO, users can confidently scale processes without the need for extensive re-optimisation.

Continuous processing, low holdup volumes, and sanitary design further enhance productivity by reducing downtime and simplifying cleaning between batches.

The system has the ability to produce consistent, monodispersed particles across varying volumes and lipid nanoparticle (LNP) chemistries—highlighting its robustness and flexibility in demanding applications such as intracellular drug delivery.

HORIZON™ platform as a transformative solution for organisations seeking to accelerate development timelines while reducing scale-up risk and cost. By bridging the gap between laboratory innovation and commercial manufacturing, Micropore Technologies sets a new benchmark for particle engineering.

  • Demonstration video
  • Benefits
  • Applications

Demonstration video

Benefits

  • Eliminate batch variability with tightly controlled highly reproducible particle size distributions using patented 316L stainless steel AXF crossflow technology.
  • Scale with confidence from R&D to manufacturing without re-optimisation, removing one of the biggest barriers to commercialisation.
  • Protect sensitive formulations through low-shear processing, preserving structure and functionality of delicate APIs, lipids, and biologics.
  • Reduce costly material loss with low holdup volumes—critical when working with expensive or limited materials.
  • Minimise downtime between batches thanks to hygienic design and faster, more efficient cleaning.
  • Accelerate development timelines using automated control for rapid process optimisation and consistent outcomes.
  • Improve process reliability with robust, low-maintenance operation suited to demanding production environments.
  • Formulate with flexibility across a wide range of chemistries and applications without compromising performance.
  • Maximise lab and facility space with a compact footprint ideal for controlled and GMP environments.

This combination enables formulators to move faster, reduce risk, and maintain product quality from early development through to full-scale production.

Applications

Whether working with emulsions, microparticles or nanoparticles, HORIZON™ systems provide a scalable and efficient approach to formulation development and manufacturing.

Pharmaceutical Companies
Long-acting injectables, lipid nanoparticles and controlled release formulations.

CDMOs
Development and manufacturing programmes requiring reliable scale-up.

Personal Care and Fragrance
Stable emulsions and encapsulation of sensitive ingredients.

Contract Encapsulation Houses
Industrial encapsulation processes requiring consistent, scalable performance.

Related products

Micropore AXF Pathfinder

The AXF-Pathfinder is a compact integrated benchtop unit that promises to reduce the cost and accelerate the development of genomic medicines.

Find out more

Micropore AXF series

Micropore’s technology enables scalable formulation of mono-disperse microspheres, nanoparticles and emulsions from lab bench to GMP manufacture significantly accelerating the efficiency of nanomedicine development.

Find out more

Micropore LDC-1

The LDC-1 uses a precision engineered circular membrane with a stirrer for droplet formation, ideal for prototyping and formulation development.

Find out more

Product Enquiry

SPEAK TO OUR AUSTRALIAN AND NEW ZEALAND TEAM

If you would like to enquire about this product, fill out this form and one of our product specialists will contact you shortly.
If you need help in the operation or repair of an instrument then please contact the Customer Help Centre directly.

Please note, product enquiries are only applicable to Australia, New Zealand, Papua New Guinea and Fiji


    Or call us instead at (02) 9541 3500